Dendrimers for Sustained Release of Compounds
Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
Attached files:Patents:US 20,110,034,422
Inventor(s):
KANNAN RANGARAMANUJAM [US]; IEZZI RAYMOND [US]; RAJAGURU BHARATH [US]; KANNAN SUJATHA [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents